Literature DB >> 15047552

Activities of newer quinolones against Escherichia coli and Klebsiella pneumoniae containing the plasmid-mediated quinolone resistance determinant qnr.

Minggui Wang1, Daniel F Sahm, George A Jacoby, Yingyuan Zhang, David C Hooper.   

Abstract

Seventeen qnr-containing transconjugants were constructed with azide-resistant Escherichia coli J53 as the recipient, and the MICs of 12 quinolones were tested by agar dilution methods. Sitafloxacin, BAYy3118, and premafloxacin had higher activity in vitro than ciprofloxacin against transconjugants and donors containing qnr. The donors had higher quinolone MICs than the transconjugants.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047552      PMCID: PMC375334          DOI: 10.1128/AAC.48.4.1400-1401.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Interaction of plasmid and host quinolone resistance.

Authors:  Luis Martínez-Martínez; Alvaro Pascual; Isabel García; John Tran; George A Jacoby
Journal:  J Antimicrob Chemother       Date:  2003-02-25       Impact factor: 5.790

2.  Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone.

Authors:  Dilek Ince; Xiamei Zhang; L Christine Silver; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

Review 3.  Mechanisms of action and resistance of older and newer fluoroquinolones.

Authors:  D C Hooper
Journal:  Clin Infect Dis       Date:  2000-08       Impact factor: 9.079

4.  Quinolone resistance from a transferable plasmid.

Authors:  L Martínez-Martínez; A Pascual; G A Jacoby
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

5.  Mechanism of plasmid-mediated quinolone resistance.

Authors:  John H Tran; George A Jacoby
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-09       Impact factor: 11.205

6.  Prevalence of plasmid-mediated quinolone resistance.

Authors:  George A Jacoby; Nancy Chow; Ken B Waites
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

7.  Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China.

Authors:  Minggui Wang; John H Tran; George A Jacoby; Yingyuan Zhang; Fu Wang; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

8.  Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase.

Authors:  J M Rodríguez-Martínez; A Pascual; I García; L Martínez-Martínez
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790

9.  Activity of and resistance to moxifloxacin in Staphylococcus aureus.

Authors:  Dilek Ince; Xiamei Zhang; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

10.  Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract.

Authors:  L J Piddock; M Johnson; V Ricci; S L Hill
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

  10 in total
  7 in total

1.  Further identification of plasmid-mediated quinolone resistance determinant in Enterobacteriaceae in Turkey.

Authors:  Hasan Nazic; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

2.  Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe.

Authors:  Hedi Mammeri; Marc Van De Loo; Laurent Poirel; Luis Martinez-Martinez; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Molecular characteristics of extended spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae and the prevalence of qnr in Extended spectrum beta-lactamase isolates in a tertiary care hospital in Korea.

Authors:  Myeong Hee Kim; Hee Joo Lee; Kyung Sun Park; Jin Tae Suh
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

Review 4.  Plasmid-mediated quinolone resistance: a multifaceted threat.

Authors:  Jacob Strahilevitz; George A Jacoby; David C Hooper; Ari Robicsek
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

5.  Protective effect of Qnr on agents other than quinolones that target DNA gyrase.

Authors:  George A Jacoby; Marian A Corcoran; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

6.  Plasmidic qnrA3 enhances Escherichia coli fitness in absence of antibiotic exposure.

Authors:  Adrien Michon; Nicolas Allou; Françoise Chau; Isabelle Podglajen; Bruno Fantin; Emmanuelle Cambau
Journal:  PLoS One       Date:  2011-09-07       Impact factor: 3.240

7.  Plasmid-mediated quinolone resistance genes transfer among enteric bacteria isolated from human and animal sources.

Authors:  Ehwarieme Daniel Ayobola; Whiliki Onoriadjeren Oscar; Ejukonemu Francis Ejovwokoghene
Journal:  AIMS Microbiol       Date:  2021-06-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.